PolyPid PYPD Stock
2.6 USD
{{ price }}
-5.454549%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
26.5M USD
LOW - HIGH [24H]
2.59
-
2.7 USD
VOLUME [24H]
11.19K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-4.91 USD
PolyPid Price Chart
PolyPid PYPD Financial and Trading Overview
| PolyPid stock price | 2.6 USD |
| Previous Close | 0.4 USD |
| Open | 0.4 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 1300 |
| Day's Range | 0.39 - 0.42 USD |
| 52 Week Range | 0.33 - 6.9 USD |
| Volume | 160.49K USD |
| Avg. Volume | 115.12K USD |
| Market Cap | 15.48M USD |
| Beta (5Y Monthly) | 1.244186 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.91 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.83 USD |
PYPD Valuation Measures
| Enterprise Value | 14.89M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.3448276 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.3559322 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.483 |
Trading Information
PolyPid Stock Price History
| Beta (5Y Monthly) | 1.244186 |
| 52-Week Change | -91.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.9 USD |
| 52 Week Low | 0.33 USD |
| 50-Day Moving Average | 0.4 USD |
| 200-Day Moving Average | 0.81 USD |
PYPD Share Statistics
| Avg. Volume (3 month) | 115.12K USD |
| Avg. Daily Volume (10-Days) | 110.77K USD |
| Shares Outstanding | 38.69M |
| Float | 29.63M |
| Short Ratio | 1.43 |
| % Held by Insiders | 4.65% |
| % Held by Institutions | 6.32% |
| Shares Short | 124.14K |
| Short % of Float | 0.34% |
| Short % of Shares Outstanding | 0.32% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -60.89% |
| Return on Equity (ttm) | -167.69% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -30852250 USD |
| Net Income Avi to Common (ttm) | -33751000 USD |
| Diluted EPS (ttm) | -1.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.43M USD |
| Total Cash Per Share (mrq) | 0.35 USD |
| Total Debt (mrq) | 12.84M USD |
| Total Debt/Equity (mrq) | 112.57 USD |
| Current Ratio (mrq) | 2.746 |
| Book Value Per Share (mrq) | 0.295 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of PolyPid
| Country | United States |
| State | N/A |
| City | Petah Tikva |
| Address | 18 Hasivim Street |
| ZIP | 4959376 |
| Phone | 972 7 4719 5700 |
| Website | https://www.polypid.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 57 |
PolyPid Ltd., a clinical-stage pharmaceutical company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which helps in the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Q&A For PolyPid Stock
What is a current PYPD stock price?
PolyPid PYPD stock price today per share is 2.6 USD.
How to purchase PolyPid stock?
You can buy PYPD shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PolyPid?
The stock symbol or ticker of PolyPid is PYPD.
Which industry does the PolyPid company belong to?
The PolyPid industry is Biotechnology.
How many shares does PolyPid have in circulation?
The max supply of PolyPid shares is 10.19M.
What is PolyPid Price to Earnings Ratio (PE Ratio)?
PolyPid PE Ratio is now.
What was PolyPid earnings per share over the trailing 12 months (TTM)?
PolyPid EPS is -4.91 USD over the trailing 12 months.
Which sector does the PolyPid company belong to?
The PolyPid sector is Healthcare.
PolyPid PYPD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Global Market Composite NQGM | 1839.71 USD — |
-3.16
|
— — | 1825.54 USD — | 1881.06 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}